发明申请
US20130287763A1 COMBINATION THERAPY FOR TREATING CANCER COMPRISING AN IGF-1R INHIBITOR AND AN AKT INHIBITOR
审中-公开
用于治疗包含IGF-1R抑制剂和AKT抑制剂的癌症的组合治疗
- 专利标题： COMBINATION THERAPY FOR TREATING CANCER COMPRISING AN IGF-1R INHIBITOR AND AN AKT INHIBITOR
- 专利标题（中）： 用于治疗包含IGF-1R抑制剂和AKT抑制剂的癌症的组合治疗
-
申请号： US13812249申请日： 2011-07-25
-
公开(公告)号： US20130287763A1公开(公告)日： 2013-10-31
- 发明人: Sriram Sathyanarayanan , Christopher Winter , Andrew Bloecher , Erin Valentine
- 申请人： Sriram Sathyanarayanan , Christopher Winter , Andrew Bloecher , Erin Valentine
- 申请人地址： US NJ Rahway
- 专利权人： MERCK SHARP & DOHME CORP.
- 当前专利权人： MERCK SHARP & DOHME CORP.
- 当前专利权人地址： US NJ Rahway
- 国际申请： PCT/US2011/045191 WO 20110725
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K45/06 ; A61K31/4375
摘要：
The present invention relates to a method of treating cancer by administering an IGF-1R specific antibody in combination with an anti-cancer agent exemplified by an Akt pathway inhibitor. The first and second amounts together comprise a therapeutically effective amount.
信息查询
